Tissue Repair is a fundamental physiological process that aims to restore the structural and functional integrity of damaged or injured tissues. It involves a series of coordinated events, including inflammation, tissue regeneration, and remodeling, orchestrated by various cell types and molecular signals. In the initial phase of tissue repair, inflammation occurs, characterized by the recruitment of immune cells, release of inflammatory mediators, and removal of debris. Following inflammation, the proliferative phase involves the regeneration of new tissue, often facilitated by stem cells or specialized cells in the affected area. Extracellular matrix components are synthesized, providing structural support for the developing tissue. The final phase, remodeling, involves the maturation and organization of the newly formed tissue to optimize its function. The success of tissue repair relies on the balance between these phases and the proper regulation of cellular activities. Chronic inflammation or impaired regeneration can lead to fibrosis or scar formation, affecting tissue function. Understanding the mechanisms of tissue repair is crucial for developing therapeutic interventions to enhance the process and promote optimal recovery following injuries, surgeries, or diseases. Ongoing research in regenerative medicine continues to explore innovative strategies for improving tissue repair outcomes and addressing various medical conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States